Growth Metrics

Edwards Lifesciences (EW) Short-term Investments (2016 - 2026)

Edwards Lifesciences has reported Short-term Investments over the past 15 years, most recently at $1.3 billion for Q4 2025.

  • For Q4 2025, Short-term Investments rose 38.42% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, up 38.42%, while the annual FY2025 figure was $1.3 billion, 38.42% up from the prior year.
  • Short-term Investments for Q4 2025 was $1.3 billion at Edwards Lifesciences, up from $1.2 billion in the prior quarter.
  • Over five years, Short-term Investments peaked at $1.3 billion in Q4 2025 and troughed at $156.4 million in Q1 2021.
  • A 5-year average of $566.5 million and a median of $469.8 million in 2023 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: plummeted 57.52% in 2021 and later skyrocketed 197.31% in 2022.
  • Year by year, Short-term Investments stood at $604.0 million in 2021, then decreased by 26.11% to $446.3 million in 2022, then rose by 12.14% to $500.5 million in 2023, then skyrocketed by 85.95% to $930.7 million in 2024, then soared by 38.42% to $1.3 billion in 2025.
  • Business Quant data shows Short-term Investments for EW at $1.3 billion in Q4 2025, $1.2 billion in Q3 2025, and $789.4 million in Q2 2025.